proxyvotesnow.com

Home › Upcoming votes › IGC Pharma, Inc.

IGC Pharma, Inc. Annual Meeting December 2, 2026: What's on the Ballot

Say on pay

Read the proxy statement on EDGAR

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in IGC Pharma, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.

#ItemProposed byBoard recommendsLast year (same kind of item)
1 Election of Claudia Grimaldi as Class A director
Director election
Board For —
2 Amend 2018 Omnibus Incentive Plan: share reserve adjustment date Board For —
3 Amend 2018 Omnibus Incentive Plan: increase annual share reserve to 20% Board For —
4 Approve grant of 5,000,000 shares under 2018 Omnibus Incentive Plan Board For —
5 Advisory vote on named executive officer compensation
Say on pay
Board For —
6 Ratify Manohar Chowdhry & Associates as auditor
Auditor
Board For 99.5% support
7 Adjournment Proposal
Adjournment
Board For —

Last year’s official results

From IGC Pharma, Inc.’s Form 8-K, filed October 14, 2025, for the meeting held October 10, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
Elect Director: Ram Mukunda——
Elect Director: James Moran——
2. Proposal to ratify the appointment of Manohar Chowdhry & Associates as the Company's independent registered public accounting firm for th99.5%—
3. Approval of the grant of 5,000,000 shares of common stock to be granted from time to time to the Company's current and new employees, adv91%—
4. To effect an amendment to our Amended and Restated Articles of Incorporation to increase the authorized number of shares of our common st92%—

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.